Trial Profile
Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 19 Oct 2021
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Gastrointestinal disorders
- Focus Therapeutic Use
- 19 Aug 2016 New trial record